Accéder au contenu
Merck

792500

Pyruvate de sodium

anhydrous grade, ≥99%, ReagentPlus®, Redi-Dri™, free-flowing, powder

Synonyme(s) :

αAcide α-cétopropionique sodium salt, Acide 2-oxopropanoïque sodium salt, Acide pyruvique sodium salt

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Toutes les photos(7)

About This Item

Formule linéaire :
CH3COCOONa
Numéro CAS:
113-24-6
Poids moléculaire :
110.04
NACRES:
NA.21
PubChem Substance ID:
329768338
UNSPSC Code:
12352100
EC Number:
204-024-4
MDL number:
MFCD00002586
Beilstein/REAXYS Number:
3568341
assay:
≥99%
grade:
anhydrous
form:
powder
solubility:
H2O: 100 mg/mL, clear, colorless to faintly yellow

Nom du produit

Pyruvate de sodium, anhydrous, free-flowing, Redi-Dri™, ReagentPlus®, ≥99%

product line

Redi-Dri™
ReagentPlus®

InChI

1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1

InChI key

DAEPDZWVDSPTHF-UHFFFAOYSA-M

SMILES string

[Na+].CC(=O)C([O-])=O

grade

anhydrous

assay

≥99%

form

powder

quality

free-flowing

loss

≤0.5% loss on drying

mp

>300 °C (lit.)

solubility

H2O: 100 mg/mL, clear, colorless to faintly yellow

cation traces

heavy metals (as Pb): ≤20 ppm

functional group

ketone

storage temp.

2-8°C

Quality Level

100

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H317,H319

Hazard Classifications

Eye Irrit. 2 - Skin Sens. 1B

Classe de stockage

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
SLCH6669
SLCH6668
SLBZ3119
SLBV6133
SLBX1167

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Rekin's Janky et al.
PLoS computational biology, 10(7), e1003731-e1003731 (2014-07-25)
Identifying master regulators of biological processes and mapping their downstream gene networks are key challenges in systems biology. We developed a computational method, called iRegulon, to reverse-engineer the transcriptional regulatory network underlying a co-expressed gene set using cis-regulatory sequence analysis.
Tetsufumi Ito et al.
The Journal of comparative neurology, 523(15), 2277-2296 (2015-04-17)
Large GABAergic (LG) neurons form a distinct cell type in the inferior colliculus (IC), identified by the presence of dense VGLUT2-containing axosomatic terminals. Although some of the axosomatic terminals originate from local and commissural IC neurons, it has been unclear
Athanasia E Christakou et al.
Lab on a chip, 15(15), 3222-3231 (2015-07-02)
We demonstrate a simple method for three-dimensional (3D) cell culture controlled by ultrasonic standing waves in a multi-well microplate. The method gently arranges cells in a suspension into a single aggregate in each well of the microplate and, by this
Philipp Müller et al.
Cancer immunology research, 2(8), 741-755 (2014-06-12)
Antibody-drug conjugates (ADC) are emerging as powerful treatment strategies with outstanding target-specificity and high therapeutic activity in patients with cancer. Brentuximab vedotin represents a first-in-class ADC directed against CD30(+) malignancies. We hypothesized that its sustained clinical responses could be related
Philipp Müller et al.
Science translational medicine, 7(315), 315ra188-315ra188 (2015-11-27)
Targeted drug delivery with antibody-drug conjugates such as the HER2-directed ado-trastuzumab emtansine (T-DM1) has emerged as a powerful strategy for cancer therapy. We show that T-DM1 is particularly effective in eliciting antitumor immunity in patients with early breast cancer (WSG-ADAPT
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique